Do Income Level and Race Influence Survival in Patients Receiving Hemodialysis?
Abstract
Background
Residence in a lower-income area has been associated with higher mortality among patients receiving dialysis. We sought to determine whether these differences persist and whether the effect of income-area on mortality is different for African Americans versus patients of other races.
Methods
We evaluated relationships between lower- and higher-income versus middle-income area residence and mortality to 5 years after adjusting for differences in baseline clinical, dialysis facility, and socioeconomic characteristics in 186,424 adult patients with end-stage renal disease initiating hemodialysis at stand-alone facilities between 1996 and 1999. We also compared mortality differences between race and income level groups using non-African Americans residing in middle-income areas as the reference group.
Results
Patients with end-stage renal disease who reside in lower-income areas were younger and more frequently African American. After adjustment, there were no mortality differences among income level groups. However, African Americans in all income level groups had lower adjusted mortality compared with the reference group (lower-income hazard ratio [HR]
=
0.771, 95% confidence interval [CI], 0.736-0.808; middle-income HR
=
0.755, 95% CI, 0.730-0.781; higher-income HR
=
0.809, 95% CI, 0.764-0.857), whereas adjusted mortality was similar among non–African-American income level groups (lower-income HR
=
1.019, 95% CI, 0.976-1.064; higher-income HR
=
1.003, 95% CI, 0.968-1.039).
Conclusion
Adjusted survival for patients receiving hemodialysis in all income areas was similar. However, this result masks the paradoxically higher survival for African American versus patients of other race and demonstrates the need to adjust for differences in demographic, clinical, provider, and socioeconomic status characteristics.
Keywords: Dialysis, End-stage renal disease, Income level, Race
Funding: Supported by the Dialysis Facility Management study, which was funded by the Agency for Healthcare Research and Quality (R01 HS-013345). The funder had no role in the design or conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the article.
Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this article.
Authorship: No organization has influenced the conduct or reporting of the work submitted. ELE, JLS, KJA, and JAS had access to the study data sets. All authors participated in planning the analyses, reviewing results, and writing the article. ELE had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
PII: S0002-9343(08)00957-1
doi:10.1016/j.amjmed.2008.08.025
© 2009 Elsevier Inc. All rights reserved.

